COVID-19 Policy
6-1-2020
If a student feels ill, you must stay home and be seen by a physician and tested for
COVID-19. You will be placed on a leave of absence until you receive test results.
IF you test positive for COVID-19, you must remain on leave. To return to
school, you must test NEGATIVE and provide the school a copy of the test results to return to school.
CDC INFORMATION
Discontinuation of Isolation for Persons with COVID
-19 Not in Healthcare Settings
Interim Guidance
Updated May 29, 2020
CDC
guidance for COVID-19 may be adapted by state and local health departments to
respond to rapidly changing local circumstances.
Summary Page
Who this is for:
Healthcare providers and
public health officials managing persons with coronavirus disease 2019
(COVID-19) under isolation who are not in healthcare settings. This includes,
but is not limited to, at home, in a hotel or dormitory room, or in a group
isolation facility.
Summary of Recent
Changes
Updates as of May 29,
2020
Added information around
the management of persons who may have prolonged viral shedding after recovery.
Updates as of May 3,
2020
·
Changed the name of the
‘non-test-based strategy’ to the ‘symptom-based strategy’ for those with
symptoms. Added a ‘time-based strategy’ and named the ‘test-based strategy’ for
asymptomatic persons with laboratory-confirmed COVID-19. Extended the home
isolation period from 7 to 10 days since symptoms first appeared for
the symptom-based strategy in persons with COVID-19 who have symptoms and from
7 to 10 days after the date of their first positive test for the time-based
strategy in asymptomatic persons with laboratory-confirmed COVID-19. This
update was made based on evidence suggesting a longer duration of viral
shedding and will be revised as additional evidence becomes available. This
time period will capture a greater proportion of contagious patients; however,
it will not capture everyone.
Updates as of April 4,
2020
·
Revised title to include
isolation in all settings other than health settings, not just home.
For
Persons with COVID-19 Under Isolation:
The
decision to discontinue home isolation for persons with confirmed or suspected
COVID-19 should be made in the context of local circumstances. Options include
a symptom-based (i.e., time-since-illness-onset and time-since-recovery
strategy) or a test-based strategy. Of note, there have been reports of
prolonged detection of RNA without direct correlation to viral culture.
1).
Symptom-based strategy
Persons
with COVID-19 who have symptoms and were directed to care for themselves
at home may discontinue isolation under the following conditions:
·
At
least 3 days (72 hours) have passed since recovery defined as
resolution of fever without the use of fever-reducing medications and improvement
in respiratory symptoms (e.g., cough, shortness of breath); and,
·
At
least 10 days have passed since symptoms first appeared.
2).
Test-based strategy Previous
recommendations for a test-based strategy remain applicable; however, a
test-based strategy is contingent on the availability of ample testing supplies
and laboratory capacity as well as convenient access to testing.
Persons
who have COVID-19 who have symptoms and were directed to care for themselves
at home may discontinue isolation under the following conditions:
·
Resolution
of fever without the use of fever-reducing medications and
·
Improvement
in respiratory symptoms (e.g., cough, shortness of breath), and
For
Persons Who have NOT had COVID-19 Symptoms but Tested Positive and are Under
Isolation:
Options
now include both a 1) time-based strategy, and 2) test-based strategy.
1).
Time-based strategy
Persons
with laboratory-confirmed COVID-19 who have not had any symptoms and were directed
to care for themselves at home may discontinue isolation under the following
conditions:
·
At
least 10 days have passed since the date of their first positive COVID-19
diagnostic test assuming they have not subsequently developed symptoms since
their positive test. If they develop symptoms, then the symptom-based or
test-based strategy should be used. Note, because symptoms cannot be used to
gauge where these individuals are in the course of their illness, it is possible that
the duration of viral shedding could be longer or shorter than 10 days after
their first positive test.
2).
Test-based strategy A
test-based strategy is contingent on the availability of ample testing supplies
and laboratory capacity as well as convenient access to testing.
Persons
with laboratory-confirmed COVID-19 who have not had any symptoms and were directed to
care for themselves at home may discontinue isolation under the following
conditions:
Other
Considerations
The
symptom-based, time-based, and test-based strategies may result in different
timeframes for discontinuation of isolation post-recovery. For all scenarios
outlined above, the decision to discontinue isolation should be made in the
context of local circumstances.
Note
that recommendations for discontinuing isolation in persons known to be
infected with COVID-19 could, in some circumstances, appear to conflict with
recommendations on when to discontinue quarantine for persons known to have
been exposed to COVID-19. CDC recommends 14 days of
quarantine after exposure based on the time it takes to
develop illness if infected. Thus, it is possible that a person known to
be infected could leave isolation earlier than a person who is quarantined
because of the possibility they are infected.
This
recommendation will prevent most, but cannot prevent all, instances of
secondary spread. The risk of transmission after recovery is likely
substantially less than that during illness; recovered persons will not be shedding
large amounts of virus by this point, if they are shedding at all. Employers and local
public health authorities can choose to apply more stringent criteria for
certain persons where a higher threshold to prevent transmission is warranted.
For
certain populations, a longer timeframe after recovery may be desired to
minimize the chance of prolonged shedding of replication-competent virus. Such
persons include:
·
healthcare personnel in close contact
with vulnerable persons at high-risk for illness and death if those persons get
COVID-19 and
Experience
from other respiratory viral infections, in particular influenza, suggests that
people with COVID-19 may shed detectable viral materials of unknown infectious
potential for an extended period of time after recovery. The best available
evidence suggests that most persons recovered from illness with detectable
viral RNA (either persistent or recurrent) are likely no longer infectious, but
conclusive evidence is not currently available. Prolonged viral shedding has
been demonstrated without direct correlation with replication competent virus.
Although persons may produce PCR-positive specimens for up to 6 weeks, it remains
unknown whether these PCR-positive samples represent the presence of infectious
virus. Such persons should consult with their healthcare provider; strategies
to address this might include additional PCR testing. When a test-based
strategy is not feasible or desired, consider consultation with local
infectious disease experts about discontinuing home isolation for patients who
might have prolonged viral shedding, including those who are immunocompromised.
Footnotes
*All test results should be final before isolation is ended.
Testing guidance is based upon limited information and is subject to change as
more information becomes available. In persons with a persistent productive
cough, SARS-CoV-2-RNA might be detected for longer periods in sputum specimens
than in respiratory specimens.
Image Maker Beauty Institute is open and following CDC guidelines
as well as state requirements concerning COVID-19.